The Industrialization Project in Biomedical Industrial Park of Changchun New Area has recently started construction, adding "new forces" to the "Changchun Pharmaceutical Valley" created by Changchun New Area.

Changchun SinoBiomaterials Co., Ltd. is a high-tech enterprise gradually growing up in Changchun New Area. After years of cultivation, development and expansion, it has become a benchmarking enterprise for the development of new products, new technologies and new solutions in the field of biomedicine. In the first half of this year, the output value of the company reached RMB 520 million, with a year-on-year increase of 595%, marking its entry into the "fast lane" of rapid development. The Industrialization Project launched this time mainly focuses on building R&D and Pilot Test Bases, production workshops and related supporting facilities. It is planned to be completed in November this year and put into operation in October next year. In the next five years, it will achieve an output value of more than RMB 10 billion, which will play an important role in expanding the scale of the medical industry in Changchun New Area and promoting the development of the real economy. In 2021, the industrial output value of enterprises above the designated size in the medical device industry in Changchun New Area achieved RMB 1.33 billion, accounting for nearly 1/3 of Changchun and more than 1/5 of Jilin Province.